Beijing Leadman Biochemistry Completes ChiNext IPO
Published: Feb 16, 2012
February 16, 2012 -- Beijing Leadman Biochemistry completed an IPO on the Shenzhen’s ChiNext exchange, raising almost 500 million RMB ($79 million). The company issued 38.4 million shares at a price of 13 RMB. Leadman produces IVD reagents, medical devices, and chemical raw materials. The issue price reflects a PE ratio of 37. In its first open market session, Leadman rose even higher, climbing 25% to 16.2 RMB per share. More details....
Stock Sumbol: (SHE: 300289)